Priming knowledge in liver
cancer across disciplines
Call for Abstracts Now Open!
Renew your membership today and enjoy
exclusive educational and networking benefits!
Growth patterns of hepatocellular carcinoma
NCBI, February 2020
Cooperation Between MYC and β-Catenin in Liver Tumorigenesis Requires Yap/
Hepatology, January 2020
Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: A randomized, double-blind, phase III trial.
J Clin Oncol, December 2019
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.
Gut, December 2019
Inducing and exploiting vulnerabilities for the treatment of liver cancer
Nature Research Journal, 2 October 2019